NO20083845L - 2,4-diaminopyrimidiner som celle-cyklus kinase inhibitorer - Google Patents
2,4-diaminopyrimidiner som celle-cyklus kinase inhibitorerInfo
- Publication number
- NO20083845L NO20083845L NO20083845A NO20083845A NO20083845L NO 20083845 L NO20083845 L NO 20083845L NO 20083845 A NO20083845 A NO 20083845A NO 20083845 A NO20083845 A NO 20083845A NO 20083845 L NO20083845 L NO 20083845L
- Authority
- NO
- Norway
- Prior art keywords
- diaminopyrimidines
- cell cycle
- kinase inhibitors
- cycle kinase
- excessive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
Foreliggende oppfinnelse omfatter forbindelser med den generelle formel (1) hvor R1, R2, R4, Rg, X, m, n og p er som definert i krav 1, som er egnet for behandling av sykdommer kjennetegnet ved for høy eller unormal celleproliferasjon, samt anvendelse av dem for fremstilling av et farmasøytisk preparat med de ovennevnte egenskaper.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06113967 | 2006-05-15 | ||
PCT/EP2007/054723 WO2007132010A1 (de) | 2006-05-15 | 2007-05-15 | 2, 4 -diamino pyrimidine als inhibitoren von zellzykluskinasen |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083845L true NO20083845L (no) | 2008-12-11 |
Family
ID=37102115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083845A NO20083845L (no) | 2006-05-15 | 2008-09-05 | 2,4-diaminopyrimidiner som celle-cyklus kinase inhibitorer |
Country Status (21)
Country | Link |
---|---|
US (1) | US8623887B2 (no) |
EP (2) | EP2357181A1 (no) |
JP (1) | JP5247681B2 (no) |
KR (1) | KR20090018955A (no) |
CN (1) | CN101443325A (no) |
AR (1) | AR060890A1 (no) |
AT (1) | ATE545641T1 (no) |
AU (1) | AU2007251553A1 (no) |
BR (1) | BRPI0712400A2 (no) |
CA (1) | CA2647238A1 (no) |
EA (1) | EA200802214A1 (no) |
EC (1) | ECSP088905A (no) |
IL (1) | IL195218A0 (no) |
MX (1) | MX2008014500A (no) |
NO (1) | NO20083845L (no) |
NZ (1) | NZ573506A (no) |
PE (2) | PE20120006A1 (no) |
TW (1) | TW200815392A (no) |
UA (1) | UA94944C2 (no) |
WO (1) | WO2007132010A1 (no) |
ZA (1) | ZA200807581B (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008077885A2 (en) * | 2006-12-22 | 2008-07-03 | Boehringer Ingelheim International Gmbh | 2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer |
CL2008001943A1 (es) | 2007-07-02 | 2009-09-11 | Boehringer Ingelheim Int | Compuestos derivados de fenil-triazol, inhibidores de enzimas de señales especificas que participan del control de la proliferacion celular; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer, infecciones, enfermedades inflamatorias y autoinmunes. |
CL2009000600A1 (es) * | 2008-03-20 | 2010-05-07 | Bayer Cropscience Ag | Uso de compuestos de diaminopirimidina como agentes fitosanitarios; compuestos de diaminopirimidina; su procedimiento de preparacion; agente que los contiene; procedimiento para la preparacion de dicho agente; y procedimiento para combatir plagas de animales y/u hongos dañinos patogenos de plantas. |
US8372974B2 (en) * | 2008-03-20 | 2013-02-12 | Boehringer Ingelheim International Gmbh | Regioselective preparation of substituted pyrimidines |
UY31714A (es) * | 2008-03-20 | 2009-11-10 | Boehringer Ingelheim Int | Preparación selectiva de pirimidinas sustituidas |
CA2738448A1 (en) | 2008-09-29 | 2010-04-01 | Boehringer Ingelheim International Gmbh | New chemical compounds |
US20110071158A1 (en) * | 2009-03-18 | 2011-03-24 | Boehringer Ingelheim International Gmbh | New compounds |
US8410126B2 (en) * | 2009-05-29 | 2013-04-02 | Boehringer Ingelheim International Gmbh | Pyrimidine inhibitors of PKTK2 |
US8933227B2 (en) | 2009-08-14 | 2015-01-13 | Boehringer Ingelheim International Gmbh | Selective synthesis of functionalized pyrimidines |
JP5539518B2 (ja) | 2009-08-14 | 2014-07-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 2−アミノ−5−トリフルオロメチルピリミジン誘導体の位置選択的調製 |
US8466155B2 (en) * | 2009-10-02 | 2013-06-18 | Boehringer Ingelheim International Gmbh | Pyrimidines |
JP5871897B2 (ja) | 2010-03-26 | 2016-03-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ピリジルトリアゾール |
US20120107304A1 (en) * | 2010-04-27 | 2012-05-03 | Boehringer Ingelheim International Gmbh | Combination therapy in treatment of oncological and fibrotic diseases |
PL2576541T3 (pl) | 2010-06-04 | 2016-10-31 | Pochodne aminopirymidyny jako modulatory lrrk2 | |
WO2012059932A1 (en) * | 2010-11-01 | 2012-05-10 | Aurigene Discovery Technologies Limited | 2, 4 -diaminopyrimidine derivatives as protein kinase inhibitors |
LT3124483T (lt) | 2010-11-10 | 2019-09-25 | Genentech, Inc. | Pirazolo aminopirimidino dariniai, kaip lrrk2 moduliatoriai |
US8710055B2 (en) | 2010-12-21 | 2014-04-29 | Boehringer Ingelheim International Gmbh | Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors |
US9260415B2 (en) * | 2013-12-05 | 2016-02-16 | Genentech, Inc. | Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality |
CA2934061A1 (en) * | 2013-12-20 | 2015-06-25 | Signal Pharmaceuticals, Llc | Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69933680T2 (de) | 1998-08-29 | 2007-08-23 | Astrazeneca Ab | Pyrimidine verbindungen |
SK287269B6 (sk) | 1998-11-10 | 2010-05-07 | Janssen Pharmaceutica N. V. | Derivát pyrimidínu, jeho použitie, spôsob jeho prípravy a farmaceutická kompozícia, kombinácia a produkt s jeho obsahom |
GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
GB0007371D0 (en) | 2000-03-28 | 2000-05-17 | Astrazeneca Uk Ltd | Chemical compounds |
GB0016877D0 (en) | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Chemical compounds |
RS94703A (en) | 2001-05-29 | 2007-02-05 | Schering Aktiengesellschaft, | Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
CN1678321A (zh) | 2002-07-29 | 2005-10-05 | 里格尔药品股份有限公司 | 用2,4-嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法 |
EP1597251B1 (en) | 2003-02-20 | 2009-06-10 | SmithKline Beecham Corporation | Pyrimidine compounds |
GB0305929D0 (en) | 2003-03-14 | 2003-04-23 | Novartis Ag | Organic compounds |
DK1663242T3 (da) * | 2003-08-07 | 2011-08-01 | Rigel Pharmaceuticals Inc | 2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler |
EP1763514A2 (en) | 2004-05-18 | 2007-03-21 | Rigel Pharmaceuticals, Inc. | Cycloalkyl substituted pyrimidinediamine compounds and their uses |
EP1598343A1 (de) | 2004-05-19 | 2005-11-23 | Boehringer Ingelheim International GmbH | 2-Arylaminopyrimidine als PLK Inhibitoren |
US7521457B2 (en) | 2004-08-20 | 2009-04-21 | Boehringer Ingelheim International Gmbh | Pyrimidines as PLK inhibitors |
US20070032514A1 (en) * | 2005-07-01 | 2007-02-08 | Zahn Stephan K | 2,4-diamino-pyrimidines as aurora inhibitors |
-
2007
- 2007-05-11 US US11/747,337 patent/US8623887B2/en active Active
- 2007-05-11 PE PE2011001452A patent/PE20120006A1/es not_active Application Discontinuation
- 2007-05-11 AR ARP070102041A patent/AR060890A1/es unknown
- 2007-05-11 PE PE2007000569A patent/PE20080068A1/es not_active Application Discontinuation
- 2007-05-14 TW TW096117060A patent/TW200815392A/zh unknown
- 2007-05-15 MX MX2008014500A patent/MX2008014500A/es unknown
- 2007-05-15 CN CNA2007800176717A patent/CN101443325A/zh active Pending
- 2007-05-15 UA UAA200813829A patent/UA94944C2/ru unknown
- 2007-05-15 AT AT07729171T patent/ATE545641T1/de active
- 2007-05-15 EP EP11159659A patent/EP2357181A1/de not_active Withdrawn
- 2007-05-15 KR KR1020087030445A patent/KR20090018955A/ko not_active Application Discontinuation
- 2007-05-15 EP EP07729171A patent/EP2027107B1/de active Active
- 2007-05-15 CA CA002647238A patent/CA2647238A1/en not_active Abandoned
- 2007-05-15 EA EA200802214A patent/EA200802214A1/ru unknown
- 2007-05-15 JP JP2009510448A patent/JP5247681B2/ja active Active
- 2007-05-15 BR BRPI0712400-7A patent/BRPI0712400A2/pt not_active IP Right Cessation
- 2007-05-15 WO PCT/EP2007/054723 patent/WO2007132010A1/de active Application Filing
- 2007-05-15 AU AU2007251553A patent/AU2007251553A1/en not_active Abandoned
- 2007-05-15 NZ NZ573506A patent/NZ573506A/en not_active IP Right Cessation
-
2008
- 2008-09-03 ZA ZA200807581A patent/ZA200807581B/xx unknown
- 2008-09-05 NO NO20083845A patent/NO20083845L/no not_active Application Discontinuation
- 2008-11-11 IL IL195218A patent/IL195218A0/en unknown
- 2008-11-21 EC EC2008008905A patent/ECSP088905A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2027107B1 (de) | 2012-02-15 |
NZ573506A (en) | 2011-12-22 |
ATE545641T1 (de) | 2012-03-15 |
UA94944C2 (ru) | 2011-06-25 |
EP2027107A1 (de) | 2009-02-25 |
PE20080068A1 (es) | 2008-03-17 |
AU2007251553A1 (en) | 2007-11-22 |
ECSP088905A (es) | 2008-12-30 |
MX2008014500A (es) | 2008-11-27 |
ZA200807581B (en) | 2010-05-26 |
IL195218A0 (en) | 2009-09-22 |
US20090163467A1 (en) | 2009-06-25 |
US8623887B2 (en) | 2014-01-07 |
BRPI0712400A2 (pt) | 2012-10-16 |
EA200802214A1 (ru) | 2009-06-30 |
WO2007132010A1 (de) | 2007-11-22 |
JP2009537485A (ja) | 2009-10-29 |
AR060890A1 (es) | 2008-07-23 |
TW200815392A (en) | 2008-04-01 |
KR20090018955A (ko) | 2009-02-24 |
JP5247681B2 (ja) | 2013-07-24 |
EP2357181A1 (de) | 2011-08-17 |
PE20120006A1 (es) | 2012-02-02 |
CA2647238A1 (en) | 2007-11-22 |
CN101443325A (zh) | 2009-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20083845L (no) | 2,4-diaminopyrimidiner som celle-cyklus kinase inhibitorer | |
NO20076059L (no) | 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer | |
NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
NO20085176L (no) | Fenyl substituerte heteroaryl-derivater og andvendelse som anti-tumor agenter | |
UA95644C2 (ru) | Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний | |
NO20092412L (no) | Hydantoinderivater anvendes som MMP-inhibitorer | |
CA2620129C (en) | Diaminopyrimidines as p2x3 and p2x2/3 modulators | |
NO20070655L (no) | 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft | |
NO20081217L (no) | Nye benzotiazolonderivater | |
NO20084850L (no) | MGLUR5 modulatorer I | |
NO20074275L (no) | 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister | |
NO20081554L (no) | Isoindollmidforbindelser og sammensetninger omfattende samme, og anvendelse derav | |
NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
NO20071246L (no) | Kinazolinonderivater og deres anvendelse som B-RAF-inhibitorer. | |
MX2007015863A (es) | Inhibidores de esfingosina cinasa. | |
MX2009000285A (es) | Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas. | |
PT1984357E (pt) | Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes | |
NO20064588L (no) | Delta d-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende den | |
NO20081454L (no) | Met-kinaseinhibitorer | |
TW200738659A (en) | Novel compounds | |
TW200740773A (en) | Diaminopyrimidines as P2X3 and P2X2/3 modulators | |
TW200736229A (en) | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors | |
TW200740799A (en) | Alpha2C adrenoreceptor agonists | |
TW200745084A (en) | Novel compounds | |
NO20084712L (no) | Nye farmasoytiske forbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |